Skip to main content

Advertisement

Log in

Cerebrovascular Complications Associated with Marijuana Use

  • Neurology of Systemic Diseases (J. Biller, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Purpose of review

In the last few years, the attitude toward marijuana in many parts of the world has shifted from illicit to legalized for medical use and to decriminalized. In parallel, there has been a gradual increase in the consumption of this product in the general population, particularly among adolescents and young adults. Marijuana is generally perceived as a harmless drug. However, data obtained in observational studies and preclinical models have established associations between cannabis use and cardiovascular events. In addition, there is emerging evidence linking marijuana use to cerebrovascular complications. Here we provide a critical review of the literature with special emphasis on the association of cannabinoids with stroke and the possible pathogenic mechanisms involved.

Recent findings

Ischemic and hemorrhagic stroke have been described in association with cannabis use, particularly in young individuals. Cerebral infarction remains the most commonly reported stroke subtype seen in marijuana users. Several pathogenic mechanisms have been proposed to explain this association, including multifocal intracranial stenosis, reversible cerebral vasoconstriction syndrome, and coexisting vascular risk factors.

Summary

Cannabis use is increasingly recognized in young individuals presenting with acute stroke. Our understanding of the pathogenic mechanisms associated with cannabis use and stroke is limited but rapidly evolving. Healthcare providers should educate patients about the potential cardiovascular and cerebrovascular complications related to marijuana or cannabinoids use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci. 2004;24(1):53–62. https://doi.org/10.1523/JNEUROSCI.4503-03.2004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wise RA. Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction. Trends Neurosci. 2009;32(10):517–24. https://doi.org/10.1016/j.tins.2009.06.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61–5. https://doi.org/10.1038/365061a0.

    Article  CAS  PubMed  Google Scholar 

  4. Devane WA, Hanus L, Breuer A, Pertwee R, Stevenson L, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992;258(5090):1946–9. https://doi.org/10.1126/science.1470919.

    Article  CAS  PubMed  Google Scholar 

  5. Puhl S. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia. Biochim Biophys Acta. 1867;2020:118462.

    Google Scholar 

  6. Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res. 2011;50(2):193–211. https://doi.org/10.1016/j.plipres.2011.01.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9–29. https://doi.org/10.1038/s41582-019-0284-z.

    Article  PubMed  Google Scholar 

  8. Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4(8):1770–804. https://doi.org/10.1002/cbdv.200790152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Pertwee RG. Handbook of Cannabis.; 2014.

  10. Pertwee RG. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem. 2010;17(14):1360–81. https://doi.org/10.2174/092986710790980050.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hillig KW, Mahlberg PG. A chemotaxonomic analysis of cannabinoid variation in cannabis (Cannabaceae). Am J Bot. 2004;91(6):966–75. https://doi.org/10.3732/ajb.91.6.966.

    Article  CAS  PubMed  Google Scholar 

  12. Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012;21(4):320–6.

    Article  PubMed  Google Scholar 

  13. Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, et al. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018;378(20):1888–97. https://doi.org/10.1056/NEJMoa1714631.

    Article  CAS  PubMed  Google Scholar 

  14. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376(21):2011–20. https://doi.org/10.1056/NEJMoa1611618.

    Article  CAS  PubMed  Google Scholar 

  15. Parmar JR, Forrest BD, Freeman RA. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Research in social and administrative pharmacy. ;12(4):638-654. 10.1016/j.sapharm.2015.09.002.

  16. Brotini S, Schievano C, Guidi L. Ultra-micronized palmitoylethanolamide: an efficacious adjuvant therapy for Parkinson's disease. CNS Neurol Disord Drug Targets. 2017;16(6):705–13. https://doi.org/10.2174/1871527316666170321124949.

    Article  CAS  PubMed  Google Scholar 

  17. Passmore MJ. The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation. International journal of geriatric psychiatry. 2008;23(1):116–7. https://doi.org/10.1002/gps.1828.

    Article  PubMed  Google Scholar 

  18. Giacoppo S, Bramanti P, Mazzon E. Sativex in the management of multiple sclerosis-related spasticity: an overview of the last decade of clinical evaluation. Multiple sclerosis and related disorders. 2017;17:22–31. https://doi.org/10.1016/j.msard.2017.06.015.

    Article  PubMed  Google Scholar 

  19. Abuse, National Institute on Drug. Marijuana use at historic highs among college-age adults. National Institute on drug abuse web site. https://www.drugabuse.gov/news-events/news-releases/2019/09/marijuana-use-at-historic-highs-among-college-age-adults. Updated 2019.

  20. Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med. 1972;287(5):209–12. https://doi.org/10.1056/NEJM197208032870501.

    Article  CAS  PubMed  Google Scholar 

  21. Rezkalla S, Kloner RA. Cardiovascular effects of marijuana. Trends in cardiovascular medicine. 2019;29(7):403–7. https://doi.org/10.1016/j.tcm.2018.11.004.

    Article  CAS  PubMed  Google Scholar 

  22. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9. https://doi.org/10.1161/01.cir.103.23.2805.

    Article  CAS  PubMed  Google Scholar 

  23. Kalla A, Krishnamoorthy PM, Gopalakrishnan A, Figueredo VM. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample. Journal of cardiovascular medicine. 2018;19(9):480–4. https://doi.org/10.2459/JCM.0000000000000681.

    Article  CAS  PubMed  Google Scholar 

  24. Rajesh M, Mukhopadhyay P, Haskó G, Liaudet L, Mackie K. Pacher Pá. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. Br J Pharmacol. 2010;160(3):688–700. https://doi.org/10.1111/j.1476-5381.2010.00712.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Slavic S, Lauer D, Sommerfeld M, Kemnitz UR, Grzesiak A, Trappiel M, et al. Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome. J Mol Med (Berl). 2013;91(7):811–23. https://doi.org/10.1007/s00109-013-1034-0.

    Article  CAS  Google Scholar 

  26. Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, Miyata K, et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation. 2009;119(1):28–36. https://doi.org/10.1161/CIRCULATIONAHA.108.811992.

    Article  CAS  PubMed  Google Scholar 

  27. Di Marzo V. The endocannabinoid system in obesity and type 2 diabetes. Diabetologia. 2008;51(8):1356–67. https://doi.org/10.1007/s00125-008-1048-2.

    Article  CAS  PubMed  Google Scholar 

  28. Nouh A, Ruland S, Schneck MJ, Pasquale D, Biller J. Reversible cerebral vasoconstriction syndrome with multivessel cervical artery dissections and a double aortic arch. J Stroke Cerebrovasc Dis. 2014;23(2):e141–3. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.08.013.

    Article  PubMed  Google Scholar 

  29. Singhal AB, Biller J, Elkind MS, Fullerton HJ, Jauch EC, Kittner SJ, et al. Recognition and management of stroke in young adults and adolescents. Neurology. 2013;81(12):1089–97. https://doi.org/10.1212/WNL.0b013e3182a4a451.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. • Desai R, Singh S, Patel K, et al. Stroke in young cannabis users (18–49 years): national trends in hospitalizations and outcomes. Int J Stroke. 2020;15(5):535–9. https://doi.org/10.1177/1747493019895651Large study describing the association of cannabins use with stroke in young patients.

    Article  PubMed  Google Scholar 

  31. Hackam DG. Cannabis and stroke: systematic appraisal of case reports. Stroke. 2015;46(3):852–6. https://doi.org/10.1161/STROKEAHA.115.008680.

    Article  CAS  PubMed  Google Scholar 

  32. Parekh T, Pemmasani S, Desai R. Marijuana use among young adults (18-44 years of age) and risk of stroke: a behavioral risk factor surveillance system survey analysis. Stroke. 2020;51(1):308–10. https://doi.org/10.1161/STROKEAHA.119.027828.

    Article  PubMed  Google Scholar 

  33. Shah S, Patel S, Paulraj S, Chaudhuri D. Association of marijuana use and cardiovascular disease: A behavioral risk factor surveillance system data analysis of 133,706 US adults. Am J Med. 2020. https://doi.org/10.1016/j.amjmed.2020.10.019.

  34. Liu M, Nabavizadeh J, Rao P, Derakhshandeh P, Springer R. Impairment of endothelial function by aerosol from marijuana leaf vaporizers. Circulation.

  35. Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N, Raul JS, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke. 2011;42(6):1778–80. https://doi.org/10.1161/STROKEAHA.110.610915.

    Article  PubMed  Google Scholar 

  36. Wolff V, Armspach J, Lauer V, et al. Cannabis-related stroke: myth or reality? Stroke. 2013;44(2):558–63. https://doi.org/10.1161/STROKEAHA.112.671347.

    Article  PubMed  Google Scholar 

  37. Burton TM, Bushnell CD. Reversible cerebral vasoconstriction syndrome. Stroke. 2019;50(8):2253–8. https://doi.org/10.1161/STROKEAHA.119.024416.

    Article  PubMed  Google Scholar 

  38. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser M. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101. https://doi.org/10.1093/brain/awm256.

    Article  PubMed  Google Scholar 

  39. Adams MD, Earnhardt JT, Dewey WL, Harris LS. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther. 1976;196(3):649–56.

    CAS  PubMed  Google Scholar 

  40. •• Richter JS, Quenardelle V, Rouyer O, et al.. 2018 A systematic review of the complex effects of cannabinoids on cerebral and peripheral circulation in animal models. Front Physiol. 9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986896/. 10.3389/fphys.2018.00622. Comprehensive review on the effect of cannabinois on the cerebral circulation in preclinical models

  41. Herning RI, Better WE, Tate K, Cadet JL. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology. 2005;64(3):488–93. https://doi.org/10.1212/01.WNL.0000150882.69371.DD.

    Article  PubMed  Google Scholar 

  42. Wolff V, Schlagowski A, Rouyer O, et al. Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke. Biomed Res Int. 2015;2015:323706–7. https://doi.org/10.1155/2015/323706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. •• Archie SR, Cucullo L. Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective. Front Pharmacol. 2019;10:1481. https://doi.org/10.3389/fphar.2019.01481Thougful review on the cerebrovascular and neurologic effects of cannabis.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Mathew RJ, Wilson WH, Humphreys D, Lowe JV, Wiethe KE. Middle cerebral artery velocity during upright posture after marijuana smoking. Acta Psychiatr Scand. 1992;86(2):173–8. https://doi.org/10.1111/j.1600-0447.1992.tb03247.x.

    Article  CAS  PubMed  Google Scholar 

  45. Alshaarawy O, Elbaz HA. Cannabis use and blood pressure levels: United States national health and nutrition examination survey, 2005-2012. J Hypertens. 2016;34(8):1507–12. https://doi.org/10.1097/HJH.0000000000000990.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Chami T, Kim CH. Cannabis abuse and elevated risk of myocardial Infarction in the young: a population-based study. Mayo Clin Proc. 2019;94(8):1647–9. https://doi.org/10.1016/j.mayocp.2019.05.008.

    Article  PubMed  Google Scholar 

  47. Desai R, Patel U, Sharma S, et al. Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States. Cureus. ;9(11). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752226/. https://doi.org/10.7759/cureus.1816.

  48. Jaladi PR, Patel V, Kuduva Rajan S, et al. Arrhythmia-related Hospitalization and comorbid cannabis use disorder: trend analysis in US hospitals (2010-2014). Cureus. ;11(9). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822885/. https://doi.org/10.7759/cureus.5607.

  49. Ravi D, Ghasemiesfe M, Korenstein D, Cascino T, Keyhani S. Associations between marijuana use and cardiovascular risk factors and outcomes: a systematic review. Ann Intern Med. 2018;168(3):187–94. https://doi.org/10.7326/M17-1548.

    Article  PubMed  PubMed Central  Google Scholar 

  50. • Auger N, Paradis G, Low N, Ayoub A, He S, Potter BJ. Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study. BMC Med. 2020;18(1):328. https://doi.org/10.1186/s12916-020-01804-6Large longitudinal cohort that investigated the risk of major vascular complications in cannabis users.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64(4):495–502. https://doi.org/10.1001/archpsyc.64.4.495.

    Article  PubMed  Google Scholar 

  52. Malhotra K, Rumalla K, Mittal MK. Association and clinical outcomes of marijuana in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2018;27(12):3479–86. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.08.011.

    Article  PubMed  Google Scholar 

  53. Di Napoli M, Zha AM, Godoy DA, et al. Prior cannabis use is associated with outcome after intracerebral hemorrhage. Cerebrovasc Dis. 2016;41(5-6):248–55. https://doi.org/10.1159/000443532.

    Article  PubMed  Google Scholar 

  54. Rumalla K, Reddy AY, Mittal MK. Association of recreational marijuana use with aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2016;25(2):452–60. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.10.019.

    Article  PubMed  Google Scholar 

  55. Behrouz R, Birnbaum L, Grandhi R, Johnson J, Misra V, Palacio S, et al. Cannabis use and outcomes in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2016;47(5):1371–3. https://doi.org/10.1161/STROKEAHA.116.013099.

    Article  PubMed  Google Scholar 

  56. Dandurand C, Ke JXC, Mekary RA, Prakash S, Redekop G, Gooderham P, et al. Cannabis use and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide retrospective cohort study. J Clin Neurosci. 2020;72:98–101. https://doi.org/10.1016/j.jocn.2019.12.066.

    Article  CAS  PubMed  Google Scholar 

  57. •• Page RL, Allen LA, Kloner RA, et al. Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American heart association. Circulation. 2020;142(10):e131–52. https://doi.org/10.1161/CIR.0000000000000883Comprehensive review on the effect of cannabinois on cardiovascular health, including cardiovascular outcomes and drug-drug interactions.

    Article  PubMed  Google Scholar 

  58. Kelkar AH, Smith NA, Martial A, Moole H, Tarantino MD, Roberts JC. An outbreak of synthetic cannabinoid–associated coagulopathy in Illinois. N Engl J Med. 2018;379(13):1216–23. https://doi.org/10.1056/NEJMoa1807652.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bayan Moustafa.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

Bayan Moustafa and Fernando D. Testai each declare no potential conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Neurology of Systemic Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moustafa, B., Testai, F.D. Cerebrovascular Complications Associated with Marijuana Use. Curr Neurol Neurosci Rep 21, 25 (2021). https://doi.org/10.1007/s11910-021-01113-2

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11910-021-01113-2

Keywords

Navigation